{
  "downs": 0,
  "mod_reports": [],
  "secure_media_embed": {},
  "_info_url": "https://api.reddit.com/api/info/",
  "gilded": 0,
  "num_comments": 8,
  "_orphaned": {},
  "hidden": false,
  "ups": 12,
  "url": "https://www.reddit.com/r/conspiracy/comments/2wl7gf/how_can_gilead_sciences_charge_84000_for_a_drug/",
  "_has_fetched": true,
  "quarantine": false,
  "name": "t3_2wl7gf",
  "user_reports": [],
  "saved": false,
  "permalink": "https://www.reddit.com/r/conspiracy/comments/2wl7gf/how_can_gilead_sciences_charge_84000_for_a_drug/?ref=search_posts",
  "over_18": false,
  "is_self": true,
  "_params": {},
  "thumbnail": "self",
  "created_utc": 1424463287.0,
  "_replaced_more": false,
  "selftext_html": "<!-- SC_OFF --><div class=\"md\"><p>re:  HEP C medication - it&#39;s always about the money,</p>\n\n<p>&quot;The basic facts are these. In December 2013, the Food and Drug Administration approved Sovaldi, and another formulation, Harvoni, which is sofosbuvir used in combination with another drug. Gilead set the price for a 12-week treatment course of Sovaldi at $84,000, amounting to $1,000 per pill. Gilead set the price of Harvoni at $94,000.</p>\n\n<p>According to researchers at Liverpool University, the actual production costs of Sovaldi for the 12-week course is in the range $68-$136. Indeed, generic sofosbuvir is currently being marketed in India at $300 per treatment course, after India refused to grant Gilead a patent for the Indian market. In other words, the U.S. price-cost markup is roughly 1,000-to-1!</p>\n\n<p>. . .Gilead has worked the political system to protect its windfall by ramping up its lobbying activities. That soared to $2.2 million in 2013, the year of FDA approval, and $2.9 million in 2014, the first year of sales. The lobbying helped to smooth the way to the massive uptake of the drug and the substantial financing by the U.S. Government of Gilead&#39;s inflated prices.&#39;</p>\n\n<p><a href=\"http://www.alternet.org/drugs/pharma-drug-bankrupting-america?akid=12813.1082038.l1pUfj&amp;rd=1&amp;src=newsletter1032175&amp;t=6\">http://www.alternet.org/drugs/pharma-drug-bankrupting-america?akid=12813.1082038.l1pUfj&amp;rd=1&amp;src=newsletter1032175&amp;t=6</a></p>\n\n<p>comments from above site:</p>\n\n<p>&quot;I&#39;M GUESSING MOST PEOPLE WILL BE TRAVELING TO INDIA TO GET THE $300 TREATMENT FOR AN $80,000 SAVINGS!&quot;</p>\n\n<p>&quot;Philadelphia\u2019s transit agency has sued Gilead Sciences Inc., accusing the company of \u201cprice-gouging\u201d on the sale of its $1,000-per-pill hepatitis C drug Sovaldi, the latest salvo in a battle between health-care payers and the pharmaceutical industry over prices.</p>\n\n<p>The Southeastern Pennsylvania Transportation Authority, or Septa, filed the lawsuit on Tuesday in U.S. District Court for the Eastern District of Pennsylvania. The suit seeks class-action status, subject to certification by a judge, on behalf of any person or entity in the U.S. who has paid \u201dexcessive\u201d prices for Sovaldi, or was unable to obtain the drug.&quot;\nThe lawsuit seeks monetary damages from Gilead.&quot;</p>\n\n<p>this seems interesting, any doctors/med students in the house,</p>\n\n<p><a href=\"http://www.germannewmedicine.ca/documents/Virus%20Theory-e.pdf\">http://www.germannewmedicine.ca/documents/Virus%20Theory-e.pdf</a></p>\n</div><!-- SC_ON -->",
  "subreddit_id": "t5_2qh4r",
  "archived": true,
  "domain": "self.conspiracy",
  "clicked": false,
  "score": 12,
  "id": "2wl7gf",
  "stickied": false,
  "media_embed": {},
  "visited": false,
  "selftext": "re:  HEP C medication - it's always about the money,\n\n\"The basic facts are these. In December 2013, the Food and Drug Administration approved Sovaldi, and another formulation, Harvoni, which is sofosbuvir used in combination with another drug. Gilead set the price for a 12-week treatment course of Sovaldi at $84,000, amounting to $1,000 per pill. Gilead set the price of Harvoni at $94,000.\n\nAccording to researchers at Liverpool University, the actual production costs of Sovaldi for the 12-week course is in the range $68-$136. Indeed, generic sofosbuvir is currently being marketed in India at $300 per treatment course, after India refused to grant Gilead a patent for the Indian market. In other words, the U.S. price-cost markup is roughly 1,000-to-1!\n\n. . .Gilead has worked the political system to protect its windfall by ramping up its lobbying activities. That soared to $2.2 million in 2013, the year of FDA approval, and $2.9 million in 2014, the first year of sales. The lobbying helped to smooth the way to the massive uptake of the drug and the substantial financing by the U.S. Government of Gilead's inflated prices.'\n\nhttp://www.alternet.org/drugs/pharma-drug-bankrupting-america?akid=12813.1082038.l1pUfj&rd=1&src=newsletter1032175&t=6\n\ncomments from above site:\n\n\"I'M GUESSING MOST PEOPLE WILL BE TRAVELING TO INDIA TO GET THE $300 TREATMENT FOR AN $80,000 SAVINGS!\"\n\n\"Philadelphia\u2019s transit agency has sued Gilead Sciences Inc., accusing the company of \u201cprice-gouging\u201d on the sale of its $1,000-per-pill hepatitis C drug Sovaldi, the latest salvo in a battle between health-care payers and the pharmaceutical industry over prices.\n\nThe Southeastern Pennsylvania Transportation Authority, or Septa, filed the lawsuit on Tuesday in U.S. District Court for the Eastern District of Pennsylvania. The suit seeks class-action status, subject to certification by a judge, on behalf of any person or entity in the U.S. who has paid \u201dexcessive\u201d prices for Sovaldi, or was unable to obtain the drug.\"\nThe lawsuit seeks monetary damages from Gilead.\"\n\n\nthis seems interesting, any doctors/med students in the house,\n\nhttp://www.germannewmedicine.ca/documents/Virus%20Theory-e.pdf",
  "hide_score": false,
  "_api_link": "https://api.reddit.com/r/conspiracy/comments/2wl7gf/how_can_gilead_sciences_charge_84000_for_a_drug/?ref=search_posts",
  "locked": false,
  "edited": false,
  "title": "How can Gilead Sciences charge $84,000 for a drug that costs less than $300 to produce?",
  "created": 1424466887.0,
  "_comments_by_id": {}
}